SARS-CoV-2 宿 CD55,CD59 H ,

Laura Gebetsberger1, Zahra Malekshahi2, Aron Teutsch2

  • 1Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute for Hygiene and Applied Immunology, Vienna, Austria.

PubMed
概括

严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 使用宿主调节体CD55,CD59和H因子来逃避补充介导的杀死. 阻止这些蛋白质恢复病毒对补充物的敏感性,揭示了一种新的免疫逃生策略.